Let's not forget the Alzheimer's study taking place overseas. Check it out as per RVX blog referring to "leading experts........" Yes, we have pipelines and yes, there is terrific potential in those areas. Faith is difficult for everyonek but my faith in this stock is very strong. I have never been a pumper, just a believer who has done my DD for over 8 yrs. and never lost faith. Reading scientific material is either boring or fascinating, it just depends on how motivated you are to find the nuggets of gold in them and put them together and that includes all pertinent scientific information and articles, nt just anything put out by Resverlogix. I have found links in many years of reading that affirm what I believe about our pipelines. You can believe anything you want and act accordingly - I am and have bought this stock during some incredible slides over the past 8 years. Make yourself happy with your own decisions and the best of luck to you Easymoney.
Epidemiological and mechanistic evidence indicate a link between low ApoA-I/HDL and neurodegenerative diseases such as dementia and Alzheimer’s disease (“AD”). Our lead molecule RVX-208 has illustrated potent and selective effects in raising plasma ApoA-I/HDL by ApoA-I production which has the potential to beneficially impact vascular dementia, mild cognitive impairment (“MCI”) and AD. With leading experts on our neurodegenerative clinical and scientific advisory board providing input and guidance, a Phase 2 clinical trial in this therapeutic area is planned to begin in the second half of 2013.